Boiron : Sales continue to trend downwards in Q3 – TP lowered to € 31.5 vs € 34
>Q3 sales down 8.2% - Sales fell by 8.2% in Q3 to € 143.1m, especially in France where they dropped by 13.9%. Performances in Europe were mixed, with sales growing in Italy but decreasing in Spain, whereas sales in the US rose significantly.So sales over the full 9 months are down by -8.4% (-9.1% at constant currencies), of which -8.9% for NPH (non-proprietary homeopathy) and -8% for OTC (over the counter) medicines.Boiron expects sales to contin...Boiron manufactures and markets homeopathic medicines. Homeopathic medicines are prepared from vegetable, animal, mineral, or chemical substances, which are diluted. Co. sells three types of products in 59 countries: Non-proprietary homeopathic medicines, OTC family medication specialties, and Other products. There are two large families of homeopathic medicines: Those associated with precise therapeutic indications and dosage, and those that do not mention a therapeutic indication or dosage. Co. supports homeopathy education and training organizations for healthcare professionals. Some of Co.'s brand names include Oscillococcinum®, Stodal®, S?datif PC®, and Coryzalia.
Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.